Leibniz-Institut für Immuntherapie (LIT)

Description

The institute develops immune cell therapies for cancer, autoimmune disease, and chronic inflammation, spanning discovery research, preclinical development, clinical trials, and implementation.

Related

• Fraunhofer Institute for Translational Medicine and Pharmacology ITMPFraunhofer ITMP conducts translational medicine and pharmacology research across preclinical, clinical, discovery, and infection-focused…
• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• XENOTHERAXENOTHERA develops a glyco-humanized antibody platform for immunological treatments, with work spanning clinical trials and products in…
• Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
• Cabaletta Bio ($CABA)Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic…
• Faron Pharmaceuticals Ltd.Develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical researchers and healthcare providers…
• ONCOMATRYX BIOPHARMA SLOncomatryx develops biotechnology programs focused on modulating the tumor microenvironment.
• OncoGenOncoGen conducts research in cancer, allergies and regenerative medicine for researchers and clinical consortia, focusing on gene and cell…
• Kyverna Therapeutics ($KYTX)Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and…
• Institute for Systems BiologyConducts systems biology research on cancer, health, infectious disease, chronic illness, and environment, while providing education,…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• ArsenalBioDevelops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on…